Gingival hyperplasia is a common side-effect of immunosuppression with
cyclosporine A. Nifedipine is often used to control hypertension in k
idney graft recipients. Analysis of gingival status in 106 children tr
ansplanted at our centre, and treated either with azathioprine, cyclos
porine A or both, revealed significantly higher degrees of gingival ov
ergrowth in those children receiving a combination of cyclosporine A a
nd nifedipine compared with those children treated with cyclosporine A
or nifedipine alone. Seven children undergoing gingivectomy at our ce
ntre over the past few years had received this combination. After a ch
ange in the antihypertensive regimen, avoiding long-term nifedipine me
dication, and improved dental care with chlorhexidine gel, we noted a
reduction in the degree of gingival hyperplasia. In the majority of pa
tients, nifedipine could be replaced by a single drug, usually hydrala
zine. We therefore recommend avoiding calcium channel blockers in the
long-term management of hypertension in patients receiving cyclosporin
e.